It's All in the Milk: Chondroitin Sulfate As Potential Preventative Therapy for Necrotizing Enterocolitis

Overview

Journal Pediatr Res

Specialties Biology
Pediatrics

Date 2020 Sep 13

PMID 32920604

Citations 7

Authors

Thomas A Knowles

Brian D Hosfield

Anthony R Pecoraro

Hongge Li

W Christopher Shelley

Troy A Markel

Affiliations

Soon will be listed here.

Abstract

Necrotizing enterocolitis (NEC) is a devastating condition affecting up to 5% of neonatal intensive care unit (NICU) admissions. Risk factors include preterm delivery, low birth weight, and antibiotic use. The pathogenesis is characterized by a combination of intestinal ischemia, necrosis of the bowel, reperfusion injury, and sepsis typically resulting in surgical resection of afflicted bowel. Targeted medical therapy remains elusive. Chondroitin sulfate (CS) holds the potential to prevent the onset of NEC through its anti-inflammatory properties and protective effect on the gut microbiome. The purpose of this review is to outline the many properties of CS to highlight its potential use in high-risk infants and attenuate the severity of NEC. The purpose of this review is to (1) discuss the interaction of CS with the infant microbiome, (2) review the anti-inflammatory properties of CS, and (3) postulate on the potential role of CS in preventing NEC. IMPACT: NEC is a costly medical burden in the United States. Breast milk is the best preventative measure for NEC, but not all infants in the NICU have access to breast milk. Novel therapies and diagnostic tools are needed for NEC. CS may be a potential therapy for NEC due to its potent anti-inflammatory properties. CS could be added to the formula in an attempt to mitigate breast milk disparities.

Citing Articles

Ferroptosis and its impact on common diseases.

Zou P, He Q, Xia H, Zhong W PeerJ. 2024; 12:e18708.

PMID: 39713140 PMC: 11663406. DOI: 10.7717/peerj.18708.

Characterising glycosaminoglycans in human breastmilk and their potential role in infant health.

Greenwood M, Murciano-Martinez P, Berrington J, Flitsch S, Austin S, Stewart C Microb Cell. 2024; 11:221-234.

PMID: 38975022 PMC: 11224681. DOI: 10.15698/mic2024.07.827.

Necrotizing enterocolitis: current understanding of the prevention and management.

Hu X, Liang H, Li F, Zhang R, Zhu Y, Zhu X Pediatr Surg Int. 2024; 40(1):32.

PMID: 38196049 PMC: 10776729. DOI: 10.1007/s00383-023-05619-3.

Hepatocyte Aquaporins AQP8 and AQP9 Are Engaged in the Hepatic Lipid and Glucose Metabolism Modulating the Inflammatory and Redox State in Milk-Supplemented Rats.

Trinchese G, Gena P, Cimmino F, Cavaliere G, Fogliano C, Garra S Nutrients. 2023; 15(16).

PMID: 37630841 PMC: 10459073. DOI: 10.3390/nu15163651.

Impact of neonatal nutrition on necrotizing enterocolitis.

Monzon N, Kasahara E, Gunasekaran A, Burge K, Chaaban H Semin Pediatr Surg. 2023; 32(3):151305.

PMID: 37257267 PMC: 10750299. DOI: 10.1016/j.sempedsurg.2023.151305.

References

Gupta A, Paria A . Etiology and medical management of NEC. Early Hum Dev. 2016; 97:17-23. DOI: 10.1016/j.earlhumdev.2016.03.008. View

Hull M, Fisher J, Gutierrez I, Jones B, Kang K, Kenny M . Mortality and management of surgical necrotizing enterocolitis in very low birth weight neonates: a prospective cohort study. J Am Coll Surg. 2014; 218(6):1148-55. DOI: 10.1016/j.jamcollsurg.2013.11.015. View

Knell J, Han S, Jaksic T, Modi B . Current Status of Necrotizing Enterocolitis. Curr Probl Surg. 2019; 56(1):11-38. DOI: 10.1067/j.cpsurg.2018.11.005. View

Li Q, An Y, Liu L, Wang X, Chen S, Wang Z . Differences in the Clinical Characteristics of Early- and Late-Onset Necrotizing Enterocolitis in Full-Term Infants: A Retrospective Case-Control Study. Sci Rep. 2017; 7:43042. PMC: 5314368. DOI: 10.1038/srep43042. View

Nanthakumar N, Meng D, Goldstein A, Zhu W, Lu L, Uauy R . The mechanism of excessive intestinal inflammation in necrotizing enterocolitis: an immature innate immune response. PLoS One. 2011; 6(3):e17776. PMC: 3061868. DOI: 10.1371/journal.pone.0017776. View

Ma B, McComb E, Gajer P, Yang H, Humphrys M, Okogbule-Wonodi A . Microbial Biomarkers of Intestinal Barrier Maturation in Preterm Infants. Front Microbiol. 2018; 9:2755. PMC: 6246636. DOI: 10.3389/fmicb.2018.02755. View

Choi Y . Necrotizing enterocolitis in newborns: update in pathophysiology and newly emerging therapeutic strategies. Korean J Pediatr. 2015; 57(12):505-13. PMC: 4316593. DOI: 10.3345/kjp.2014.57.12.505. View

Meinzen-Derr J, Poindexter B, Wrage L, Morrow A, Stoll B, Donovan E . Role of human milk in extremely low birth weight infants' risk of necrotizing enterocolitis or death. J Perinatol. 2008; 29(1):57-62. PMC: 2801431. DOI: 10.1038/jp.2008.117. View

Herrmann K, Carroll K . An exclusively human milk diet reduces necrotizing enterocolitis. Breastfeed Med. 2014; 9(4):184-90. PMC: 4025624. DOI: 10.1089/bfm.2013.0121. View

10.

Hair A, Peluso A, Hawthorne K, Perez J, Smith D, Khan J . Beyond Necrotizing Enterocolitis Prevention: Improving Outcomes with an Exclusive Human Milk-Based Diet. Breastfeed Med. 2016; 11(2):70-4. PMC: 4782036. DOI: 10.1089/bfm.2015.0134. View

11.

Lucas A, Cole T . Breast milk and neonatal necrotising enterocolitis. Lancet. 1990; 336(8730):1519-23. DOI: 10.1016/0140-6736(90)93304-8. View

12.

Sitarik A, Bobbitt K, Havstad S, Fujimura K, Levin A, Zoratti E . Breast Milk Transforming Growth Factor β Is Associated With Neonatal Gut Microbial Composition. J Pediatr Gastroenterol Nutr. 2017; 65(3):e60-e67. PMC: 5596927. DOI: 10.1097/MPG.0000000000001585. View

13.

Guner Y, Franklin A, Chokshi N, Castle S, Pontarelli E, Wang J . P-glycoprotein induction by breast milk attenuates intestinal inflammation in experimental necrotizing enterocolitis. Lab Invest. 2011; 91(11):1668-79. PMC: 3909679. DOI: 10.1038/labinvest.2011.113. View

14.

Profit J, Gould J, Bennett M, Goldstein B, Draper D, Phibbs C . Racial/Ethnic Disparity in NICU Quality of Care Delivery. Pediatrics. 2017; 140(3). PMC: 5574732. DOI: 10.1542/peds.2017-0918. View

15.

Sigurdson K, Morton C, Mitchell B, Profit J . Correction: Disparities in NICU quality of care: a qualitative study of family and clinician accounts. J Perinatol. 2018; 38(8):1123. PMC: 6887837. DOI: 10.1038/s41372-018-0166-z. View

16.

Simental-Mendia M, Sanchez-Garcia A, Vilchez-Cavazos F, Acosta-Olivo C, Pena-Martinez V, Simental-Mendia L . Effect of glucosamine and chondroitin sulfate in symptomatic knee osteoarthritis: a systematic review and meta-analysis of randomized placebo-controlled trials. Rheumatol Int. 2018; 38(8):1413-1428. DOI: 10.1007/s00296-018-4077-2. View

17.

Hori Y, Hoshino J, Yamazaki C, Sekiguchi T, Miyauchi S, Horie K . Effects of chondroitin sulfate on colitis induced by dextran sulfate sodium in rats. Jpn J Pharmacol. 2001; 85(2):155-60. DOI: 10.1254/jjp.85.155. View

18.

Franzosa E, Huang K, Meadow J, Gevers D, Lemon K, Bohannan B . Identifying personal microbiomes using metagenomic codes. Proc Natl Acad Sci U S A. 2015; 112(22):E2930-8. PMC: 4460507. DOI: 10.1073/pnas.1423854112. View

19.

Staude B, Oehmke F, Lauer T, Behnke J, Gopel W, Schloter M . The Microbiome and Preterm Birth: A Change in Paradigm with Profound Implications for Pathophysiologic Concepts and Novel Therapeutic Strategies. Biomed Res Int. 2018; 2018:7218187. PMC: 6189679. DOI: 10.1155/2018/7218187. View

20.

Gonzalez-Rivera R, Culverhouse R, Hamvas A, Tarr P, Warner B . The age of necrotizing enterocolitis onset: an application of Sartwell's incubation period model. J Perinatol. 2011; 31(8):519-23. PMC: 3145821. DOI: 10.1038/jp.2010.193. View